Article info
BCS Abstracts 2011
160 High dose octreotide; a novel therapy for the treatment of drug refractory postural orthostatic tachycardia syndrome in patients with joint hypermobility syndrome
Citation
160 High dose octreotide; a novel therapy for the treatment of drug refractory postural orthostatic tachycardia syndrome in patients with joint hypermobility syndrome
Publication history
- First published June 9, 2011.
Online issue publication
January 18, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.